162 related articles for article (PubMed ID: 30518623)
1. Bexarotene - a novel modulator of AURKA and the primary cilium in
Chowdhury P; Powell RT; Stephan C; Uray IP; Talley T; Karki M; Tripathi DN; Park YS; Mancini MA; Davies P; Dere R
J Cell Sci; 2018 Dec; 131(24):. PubMed ID: 30518623
[TBL] [Abstract][Full Text] [Related]
2. Therapeutically actionable signaling node to rescue AURKA driven loss of primary cilia in VHL-deficient cells.
Chowdhury P; Perera D; Powell RT; Talley T; Tripathi DN; Park YS; Mancini MA; Davies P; Stephan C; Coarfa C; Dere R
Sci Rep; 2021 May; 11(1):10461. PubMed ID: 34002003
[TBL] [Abstract][Full Text] [Related]
3. β-catenin links von Hippel-Lindau to aurora kinase A and loss of primary cilia in renal cell carcinoma.
Dere R; Perkins AL; Bawa-Khalfe T; Jonasch D; Walker CL
J Am Soc Nephrol; 2015 Mar; 26(3):553-64. PubMed ID: 25313256
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitination and regulation of AURKA identifies a hypoxia-independent E3 ligase activity of VHL.
Hasanov E; Chen G; Chowdhury P; Weldon J; Ding Z; Jonasch E; Sen S; Walker CL; Dere R
Oncogene; 2017 Jun; 36(24):3450-3463. PubMed ID: 28114281
[TBL] [Abstract][Full Text] [Related]
5. VHL loss predicts response to Aurora kinase A inhibitor in renal cell carcinoma cells.
Ding XF; Zhou J; Chen G; Wu YL
Mol Med Rep; 2018 Jul; 18(1):1206-1210. PubMed ID: 29845253
[TBL] [Abstract][Full Text] [Related]
6. VHL inactivation induces HEF1 and Aurora kinase A.
Xu J; Li H; Wang B; Xu Y; Yang J; Zhang X; Harten SK; Shukla D; Maxwell PH; Pei D; Esteban MA
J Am Soc Nephrol; 2010 Dec; 21(12):2041-6. PubMed ID: 20864688
[TBL] [Abstract][Full Text] [Related]
7. Rho-associated kinase 1 inhibition is synthetically lethal with von Hippel-Lindau deficiency in clear cell renal cell carcinoma.
Thompson JM; Nguyen QH; Singh M; Pavesic MW; Nesterenko I; Nelson LJ; Liao AC; Razorenova OV
Oncogene; 2017 Feb; 36(8):1080-1089. PubMed ID: 27841867
[TBL] [Abstract][Full Text] [Related]
8. Formation of primary cilia in the renal epithelium is regulated by the von Hippel-Lindau tumor suppressor protein.
Esteban MA; Harten SK; Tran MG; Maxwell PH
J Am Soc Nephrol; 2006 Jul; 17(7):1801-6. PubMed ID: 16775032
[TBL] [Abstract][Full Text] [Related]
9. Primary cilium formation requires von hippel-lindau gene function in renal-derived cells.
Lutz MS; Burk RD
Cancer Res; 2006 Jul; 66(14):6903-7. PubMed ID: 16849532
[TBL] [Abstract][Full Text] [Related]
10. VHL enhances 9-cis-retinoic acid treatment by down-regulating retinoid X receptor α in renal cell carcinomas.
Wang F; Wang LS; Gao YH; Yao XD
Biochem Biophys Res Commun; 2020 Mar; 523(2):535-541. PubMed ID: 31928714
[TBL] [Abstract][Full Text] [Related]
11. Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor.
Lolkema MP; Mans DA; Ulfman LH; Volpi S; Voest EE; Giles RH
Eur J Hum Genet; 2008 Jan; 16(1):73-8. PubMed ID: 17912253
[TBL] [Abstract][Full Text] [Related]
12. Failure to reabsorb the primary cilium induces cellular senescence.
Jeffries EP; Di Filippo M; Galbiati F
FASEB J; 2019 Apr; 33(4):4866-4882. PubMed ID: 30596512
[TBL] [Abstract][Full Text] [Related]
13. Distinct von Hippel-Lindau gene and hypoxia-regulated alterations in gene and protein expression patterns of renal cell carcinoma and their effects on metabolism.
Leisz S; Schulz K; Erb S; Oefner P; Dettmer K; Mougiakakos D; Wang E; Marincola FM; Stehle F; Seliger B
Oncotarget; 2015 May; 6(13):11395-406. PubMed ID: 25890500
[TBL] [Abstract][Full Text] [Related]
14. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
16. High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma.
Wolff NC; Pavía-Jiménez A; Tcheuyap VT; Alexander S; Vishwanath M; Christie A; Xie XJ; Williams NS; Kapur P; Posner B; McKay RM; Brugarolas J
Oncotarget; 2015 Jul; 6(19):16951-62. PubMed ID: 26219258
[TBL] [Abstract][Full Text] [Related]
17. Identification of the Lipodepsipeptide MDN-0066, a Novel Inhibitor of VHL/HIF Pathway Produced by a New Pseudomonas Species.
Cautain B; de Pedro N; Schulz C; Pascual J; Sousa Tda S; Martin J; Pérez-Victoria I; Asensio F; González I; Bills GF; Reyes F; Genilloud O; Vicente F
PLoS One; 2015; 10(5):e0125221. PubMed ID: 26018559
[TBL] [Abstract][Full Text] [Related]
18. von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME.
Tedesco L; Elguero B; Pacin DG; Senin S; Pollak C; Garcia Marchiñena PA; Jurado AM; Isola M; Labanca MJ; Palazzo M; Yankilevich P; Fuertes M; Arzt E
Cell Death Dis; 2019 Mar; 10(4):266. PubMed ID: 30890701
[TBL] [Abstract][Full Text] [Related]
19. INPP5E interacts with AURKA, linking phosphoinositide signaling to primary cilium stability.
Plotnikova OV; Seo S; Cottle DL; Conduit S; Hakim S; Dyson JM; Mitchell CA; Smyth IM
J Cell Sci; 2015 Jan; 128(2):364-72. PubMed ID: 25395580
[TBL] [Abstract][Full Text] [Related]
20. pVHL and GSK3beta are components of a primary cilium-maintenance signalling network.
Thoma CR; Frew IJ; Hoerner CR; Montani M; Moch H; Krek W
Nat Cell Biol; 2007 May; 9(5):588-95. PubMed ID: 17450132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
